Advanced Research on Immune Checkpoint Inhibitor Therapy

被引：3

作者：

Imai, Hisao ^{[1
]}

Kaira, Kyoichi ^{[1
]}

Kagamu, Hiroshi ^{[1
]}

机构：

[1] Saitama Med Univ, Int Med Ctr, Dept Resp Med, Hidaka, Saitama 3501298, Japan

来源：

JOURNAL OF CLINICAL MEDICINE | 2022年 / 11卷 / 18期

关键词：

ADVERSE EVENTS; IMMUNOTHERAPY; CANCER; PD-1; SYSTEM;

D O I：

10.3390/jcm11185392

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 20 条

[1] Clinical Challenges of Immune Checkpoint Inhibitors [J].

de Miguel, Maria ;

Calvo, Emiliano .

CANCER CELL, 2020, 38 (03) :326-333

[2] Cancer immunoediting: from immunosurveillance to tumor escape [J].

Dunn, GP ;

Bruce, AT ;

Ikeda, H ;

Old, LJ ;

Schreiber, RD .

NATURE IMMUNOLOGY, 2002, 3 (11) :991-998

[3] Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers [J].

Goodman, Aaron M. ;

Kato, Shumei ;

Bazhenova, Lyudmila ;

Patel, Sandip P. ;

Frampton, Garrett M. ;

Miller, Vincent ;

Stephens, Philip J. ;

Daniels, Gregory A. ;

Kurzrock, Razelle .

MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) :2598-2608

[4] Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors [J].

Hargadon, Kristian M. ;

Johnson, Coleman E. ;

Williams, Corey J. .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 :29-39

[5] INDUCED EXPRESSION OF PD-1, A NOVEL MEMBER OF THE IMMUNOGLOBULIN GENE SUPERFAMILY, UPON PROGRAMMED CELL-DEATH [J].

ISHIDA, Y ;

AGATA, Y ;

SHIBAHARA, K ;

HONJO, T .

EMBO JOURNAL, 1992, 11 (11) :3887-3895

[6] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J].

Iwai, Y ;

Ishida, M ;

Tanaka, Y ;

Okazaki, T ;

Honjo, T ;

Minato, N .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12293-12297

[7] Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion [J].

Jhunjhunwala, Suchit ;

Hammer, Christian ;

Delamarre, Lelia .

NATURE REVIEWS CANCER, 2021, 21 (05) :298-312

[8] A Bayesian Network Meta-Analysis of First-Line Treatments for Non-Small Cell Lung Cancer with High Programmed Death Ligand-1 Expression [J].

Kim, Jung Han ;

Jeong, Soo Young ;

Lee, Jae-Jun ;

Park, Sung Taek ;

Kim, Hyeong Su .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)

[9] Impact of high tumor mutational burden in solid tumors and challenges for biomarker application [J].

McNamara, Mairead G. ;

Jacobs, Timothy ;

Lamarca, Angela ;

Hubner, Richard A. ;

Valle, Juan W. ;

Amir, Eitan .

CANCER TREATMENT REVIEWS, 2020, 89

[10] Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs [J].

Mouri, Atsuto ;

Kaira, Kyoichi ;

Yamaguchi, Ou ;

Hashimoto, Kousuke ;

Miura, Yu ;

Shiono, Ayako ;

Shinomiya, Shun ;

Imai, Hisao ;

Kobayashi, Kunihiko ;

Kagamu, Hiroshi .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)

← 1 2 →